Skip to main content

2023 IKCS: North America Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Pratik Rane, MBA, PhD

Director
Merck. & Co. Inc., Rahway, NJ, USA

Pratik Rane. MBA, PhD
Director CORE Oncology at Merck & Co., Inc.

Poster(s):

54: Pembrolizumab plus lenvatinib vs. nivolumab plus ipilimumab in patients with clear cell renal cell carcinoma with IMDC risk intermediate or poor: A matching adjusted indirect comparison (MAIC)